Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
finviz - Google News
Get the latest updates from finviz - Google News directly as they happen.
Follow now 34 followers
Latest posts
Last updated 6 days ago
Tech turmoil: NVDA and AVGO lead declines, Visa remains resilient in financials - investingLive
29 days ago
Tech turmoil: NVDA and AVGO lead declines, Visa remains resilient in financials...
Tech sector struggles: Microsoft and Nvidia dip while Tesla and Walmart shine - investingLive
29 days ago
Tech sector struggles: Microsoft and Nvidia dip while Tesla and Walmart shine...
Tech turmoil: Semiconductors soar, Meta falters - investingLive
about 1 month ago
Tech turmoil: Semiconductors soar, Meta falters investingLive
CoreWeave Investors Sell Over $1 Billion in Shares as IPO Lock-up Ends - Startup Ecosystem Canada
about 1 month ago
CoreWeave Investors Sell Over $1 Billion in Shares as IPO Lock-up Ends...
Tech stocks show mixed results: Healthcare sector surprises with strong gains - investingLive
about 1 month ago
Tech stocks show mixed results: Healthcare sector surprises with strong gains investingLive
Snowflake Inc. Outpaces Market Gains, But Faces Challenges Ahead - AInvest
about 1 month ago
Snowflake Inc. Outpaces Market Gains, But Faces Challenges Ahead AInvest
Tech sector rallies while semiconductors face turbulence - investingLive
about 1 month ago
Tech sector rallies while semiconductors face turbulence investingLive
Automotive stocks rev up as tech lags: A snapshot of today's market - investingLive
about 1 month ago
Automotive stocks rev up as tech lags: A snapshot of today's market...
Wix.com: Raymond James Maintains Strong Buy with Lower PT to $200 from $250 - AInvest
about 1 month ago
Wix.com: Raymond James Maintains Strong Buy with Lower PT to $200 from...
Klaviyo: Macquarie Keeps Neutral Rating, Raises PT to $37. - AInvest
about 1 month ago
Klaviyo: Macquarie Keeps Neutral Rating, Raises PT to $37. AInvest
EyePoint Pharmaceuticals CEO to Participate in H.C. Wainwright Ophthalmology Conference. - AInvest
about 1 month ago
EyePoint Pharmaceuticals CEO to Participate in H.C. Wainwright Ophthalmology Conference. AInvest
Technology sector mixed, financials face downturn, and healthcare stocks gain - investingLive
about 1 month ago
Technology sector mixed, financials face downturn, and healthcare stocks gain investingLive